By Dennis Ford, Founder & CEO, LSN
LSN would like to wish you all a happy Thanksgiving. We are thankful for your support and engagement on our path to build connections between early stage life science technologies and investors. We wish you all the greatest success in building your respective buinesses and moving new treatments to market.
As is LSN’s Thanksgiving tradition, we’re serving up the 10 most recent life science investment mandates gathered by LSN Research. These mandates show the breadth of coverage that LSN has among life science investors, with investors including international PE firms, expert regional investors, and global pharma firms. If one of these investors is a fit for your opportunity, we’d love to hear from you.
While you enjoy the spread on your own tables at home, click the mandates below to see what the LSN Investor Platform is serving up: